EMAIL THIS PAGE TO A FRIEND

Oncology Reports

JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.


PMID 25405520

Abstract

We're sorry this abstract is currently not available.